Brands: Zemplar · Paricalcitol
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Dr.Reddy's laboratories Limited | unknown | 12 | SUPPLYING |
| MARKSANS PHARMA LIMITED | unknown | 6 | SUPPLYING |
| TIME CAP LABORATORIES, INC | unknown | 3 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 2 | SUPPLYING |
| AbbVie Inc. | unknown | 2 | EXITED 2027 |
Shortages, recalls, and registration changes attached to this drug concept.
Paricalcitol Capsule — reported in shortage by AbbVie Inc.. Therapeutic category: Endocrinology/Metabolism.
Paricalcitol Capsule — reported in shortage by AbbVie Inc.. Therapeutic category: Endocrinology/Metabolism.
Failed Content Uniformity Specifications — Recalling firm: AbbVie Inc. — Nationwide
Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules. — Recalling firm: Dr. Reddy's Laboratories, Inc. — Nationwide
Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules. — Recalling firm: Dr. Reddy's Laboratories, Inc. — Nationwide
Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules. — Recalling firm: Dr. Reddy's Laboratories, Inc. — Nationwide
Pill